CA2216704A1 - Nouveaux peptides et medicaments pour les maladies osseuses contenant ces peptides comme ingredient actif - Google Patents

Nouveaux peptides et medicaments pour les maladies osseuses contenant ces peptides comme ingredient actif

Info

Publication number
CA2216704A1
CA2216704A1 CA002216704A CA2216704A CA2216704A1 CA 2216704 A1 CA2216704 A1 CA 2216704A1 CA 002216704 A CA002216704 A CA 002216704A CA 2216704 A CA2216704 A CA 2216704A CA 2216704 A1 CA2216704 A1 CA 2216704A1
Authority
CA
Canada
Prior art keywords
peptide
remedy
active ingredient
same
bone diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002216704A
Other languages
English (en)
Other versions
CA2216704C (fr
Inventor
Kenji Sakamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP10168195A external-priority patent/JP3398255B2/ja
Application filed by Individual filed Critical Individual
Publication of CA2216704A1 publication Critical patent/CA2216704A1/fr
Application granted granted Critical
Publication of CA2216704C publication Critical patent/CA2216704C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002216704A 1995-04-03 1996-04-03 Nouveaux peptides et medicaments pour les maladies osseuses contenant ces peptides comme ingredient actif Expired - Fee Related CA2216704C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10168195A JP3398255B2 (ja) 1995-04-03 1995-04-03 新規ペプチド及びそれを有効成分とする骨疾患治療薬
JP7/101681 1995-04-03
PCT/JP1996/000915 WO1996031530A1 (fr) 1995-04-03 1996-04-03 Nouveaux peptides et medicaments pour les maladies osseuses contenant ces peptides comme ingredient actif

Publications (2)

Publication Number Publication Date
CA2216704A1 true CA2216704A1 (fr) 1996-10-10
CA2216704C CA2216704C (fr) 2007-06-26

Family

ID=38279060

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002216704A Expired - Fee Related CA2216704C (fr) 1995-04-03 1996-04-03 Nouveaux peptides et medicaments pour les maladies osseuses contenant ces peptides comme ingredient actif

Country Status (1)

Country Link
CA (1) CA2216704C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023272658A1 (fr) * 2021-06-30 2023-01-05 北京泽勤生物医药有限公司 Polypeptide pour améliorer l'activité des ostéoblastes, et son utilisation dans le traitement d'une maladie orthopédique

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023272658A1 (fr) * 2021-06-30 2023-01-05 北京泽勤生物医药有限公司 Polypeptide pour améliorer l'activité des ostéoblastes, et son utilisation dans le traitement d'une maladie orthopédique

Also Published As

Publication number Publication date
CA2216704C (fr) 2007-06-26

Similar Documents

Publication Publication Date Title
AU5633886A (en) Biologically active lysine containing octapeptides
ATE73459T1 (de) Pharmazeutische zusammensetzungen, welche ein dipeptid enthalten.
EP0528312A3 (fr) Peptides cycliques et leur utilisation
MX9502034A (es) Formulacion estable, liofilizada, que comprende una proteina y equipo de dosificacion.
AU1633200A (en) Human parathyroid hormone modifications, preparation and use
CA2091873A1 (fr) Derives de la parathormone
EP0341915A3 (fr) Peptides antiagrégatifs
CA2022437A1 (fr) Analogues de la lhrh de taille reduite
AU6819294A (en) Oral drug delivery compositions and methods
CA2050300A1 (fr) Proteines inhibant le tnf et leur preparation
CA2303395A1 (fr) Traitement de l'obesite
AU1377092A (en) Peptides for treatment
AU682638B2 (en) Peptide, bronchodilator and blood flow ameliorant
EP0737690A3 (fr) Agent antihypertensif de caséine et sa préparation
AU585167B2 (en) Novel substrate peptides
CA2216704A1 (fr) Nouveaux peptides et medicaments pour les maladies osseuses contenant ces peptides comme ingredient actif
AU5162196A (en) Novel peptides and remedy for bone diseases containing the same as active ingredient
EP0328089A3 (fr) Analogues des LHRH à dimension réduite
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
AU7435298A (en) Compositions for enhancing immunosuppressants' pharmaceutical acti vities
WO1998056824A3 (fr) Incorporation d'analogues d'acides amines a action pharmacologique dans des proteines
TH35998A (th) Lh-rh เป็ปไทด์ อะนาล็อก ประโยชน์ของสิ่งเหล่านั้นและองค์ประกอบทางเภสัชกรรมซึ่งประกอบด้วยสิ่งเหล่านั้น
MX9707904A (es) Analogos del factor de liberacion de la hormona del crecimiento.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed